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made preoperatively was modified in 10% of cases (n=21). In 54% of
cases, TOE confirmed the diagnosis previously established by transthoracic
echocardiography, in 10% of cases the diagnosis made preoperatively was
changed, and in 28% of TOE has provided diagnostic and therapeutic solu-
tion. The results found for each type of surgical pathology are reported in
Table
Discussion: TOE performed routinely during cardiac surgery may lead to
changes in surgery, particularly in the aortic pathology and valvular diseases.
In about half of the indications for which review is requested, the supply of
TOE is decisive and modifies the treatment instituted.
Conclusion: Our study confirms the value of TOE in cardiac surgery, in
addition to the indications found in our series of patients, others such as aortic
dissection or pulmonary embolism major benefit from the addition of TOE.
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Background: Cardiovascular magnetic resonance (CMR) with endocardial
delineation of the right ventricle is the gold standard to measure right ventri-
cular ejection fraction (RVEF). Longitudinal shortening is historically known
to be the predominant part of its global systolic function and less attention has
been paid to the transversal contraction. The aim of this study was to evaluate
RV transverse motion in a large cohort of patients referred for CMR and
assess its relationship with RVEF.
Method: We retrospectively analyzed the CMR scans of 300 consecu-
tive patients referred for CMR between January and December 2010.
Reference RV ejection fraction was determined from short axis sequence
after delineating endocardial contours. Transverse parameters called RV
fractional diameter changes were calculated after measuring RV diastolic
and systolic diameters at basal and medial level in short axis view (respec-
tively FBDC and FMDC). We also measured the tricuspid annular plane
systolic excursion (TAPSE) in the four chambers view as a longitudinal
reference.
Results: Population was divided into 2 groups according the RVEF.
250 patients had a preserved RVEF (>40%) and 50 had a RV dysfunction
(RVEF≤40%). Both transverse and longitudinal motions were significantly
reduced in the group with RV dysfunction (p<.0001). After ROC analysis,
areas under the curve for FBDC, FMDC and TAPSE, were respectively 0,79,
0,82 and 0,72 with the highest sensitivity and specificity of 68% and 88% for
FMDC (threshold at 19.9%) to predict RVEF. Above all, FMDC had a 93%
negative predictive value of altered RVEF.
Conclusion: Right ventricular transversal systolic function markers,
especially at the medial level, appear to be accurate for assessment of RV
function by CMR. They are reliable to rule out an RV dysfunction in clinical
practice.
Keywords : Right ventricular ejection fraction, transversal systolic func-
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Myocardial injury in diabetes mellitus type 2 (DM-2) is associated not only
with insulin resistance, hyperinsulinemia and glucose toxicity, but also with
the action of anti-inflammatory cytokins, which accelerate the development of
atherosclerotic changes. One of the representatives of cytokins is interleukin-
6 (IL-6). Its activation is a marker of disease severity and the predictor of
development of late cardiovascular complications. However, the extent of IL-
6 involvement into the development of diastolic dysfunction (DD), typical for
metabolic cardiomyopathy (MC), is not well studied.
Therefore, the aim of our research was to evaluate the correlation between
the maximal velocity of early diastolic stream E – stream velocity caused by
atrial systoles A ratio and the level of IL-6 in patients with DM-2.
Methods: 38 patients (35-60 years old) with DM-2 without severe compli-
cations were examined. Duration of DM-2 was from 1 to 8 years. The level of
IL-6 was determined by immune-enzyme assay. The maximal velocity of early
diastolic stream E; stream velocity, caused by atrial systoles A; and an E/A ratio
were measured by heart sonography. Control group included 20 relatively
healthy individuals. Correlation analysis was applied to all studied indexes. Cor-
relation coefficient and degree of reliability of received data were counted.
Results: Mean level of E/A composed 0,93±0,04 (p<0,05) in the group of
patients with DM-2 and 1,4±0,075 (p<0,05) in the control group. The mean
level of IL-6 counted 10,7±0,27 (p<0,05) in group of patients with DM-2 and
8,83±0,22 in the control group (p<0,05). A significant reliable negative corre-
lation was revealed between E/A ratio and IL-6 level (Spearman’s rank corre-
lation coefficient R –0,32 (p<0,05)).
Conclusion: The received data prove that IL-6 contributes the development
of diastolic dysfunction in patients with MC and DM-2. IL-6 favours the devel-
opment of DD first, following systolic dysfunction in patients with DM-2.
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Introduction: Ivabradine is a selective heart-rate-lowering agent that acts
on the sinoatrial node without influence on myocardial contractility and car-
diac output. Physiological effects of ivabradine during dobutamine infusion
have never been studied.
Methods: The study included 11 healthy subjects (82% men, aged 29.1±
4.7 years). All underwent dobutamine transthoracic echocardiography before
and after ivabradine (3 hours after 5 mg of ivabradine). Baseline left ventric-
ular longitudinal global strain by speckle tracking and stroke volume at rest
and during low dose of dobutamine (when heart rate increased by more than
10 points from baseline) were compared to those obtained under ivabradine.
Results: Baseline heart rate (64±8 bpm) decreased in 7 subjects (68±7 bpm
vs. 60±6 bpm, P=0.009) but paradoxically increased in 3. Dobutamine rate
required to increase the heart rate by 10 points was similar with and without
ivabradine (11±2γ/kg/min vs. 12±3 γ/kg/min, P=0.4). Overall, global strain
increased under low dose dobutamine before (–20±2% vs. –23±2%, P=0.008)
and after ivabradine (–21±2% vs. –23±3%, P< 0.001). Interestingly, in the
7 subjects that responded to ivabradine, global strain (–23±2% vs. –25±1%,
P=0.006) and stroke volume (102±17 ml vs. 110±20 ml, P=0.05) more
increased under dobutamine with ivabradine.
Conclusion: In healthy subjects, heart rate reduction obtained by ivabra-
dine allows to increase myocardial contractility and stroke volume for a sim-
ilar rate of dobutamine. This propriety may be useful in decompensate heart
failure patients with rapid tachycardia induced by catecholamine infusion.
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